Cartesian Therapeutics, Inc. (RNAC) vs RxSight, Inc. (RXST)
A side-by-side comparison of Cartesian Therapeutics, Inc. and RxSight, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
RNAC
Cartesian Therapeutics, Inc.
$6.94HealthcareDelayed quote: Oct 6, 2026, 3:09 PM EDT
RXST
RxSight, Inc.
$4.62HealthcareDelayed quote: Oct 6, 2026, 3:10 PM EDT
Total return — RNAC vs RXST
growth of $100 · dividends reinvested · last 5yRNAC -93.4% (-41.9%/yr)RXST -70.3% (-21.5%/yr)RXST compounded faster over this window
RNAC RXST
RNAC vs RXST: by the numbers
- •RNAC is the larger company ($204M vs $191M market cap).
- •Both run net losses; RXST's is the smaller (-36.80% vs -10422.48% net margin).
- •RXST grew revenue faster over the past five years (48.85% vs -50.01% CAGR).
Metrics side by side
Valuation
| Metric | RNAC | RXST |
|---|---|---|
| P/S ratio | 137.96 | 1.50 |
| P/B ratio | N/A | 0.73 |
Profitability
| Metric | RNAC | RXST |
|---|---|---|
| Gross margin | 100.00% | 77.50% |
| Operating margin | -3099.93% | -43.20% |
| Net margin | -10422.48% | -36.80% |
| ROE | N/A | -17.83% |
| ROIC | -33.10% | -20.24% |
Growth (annualized)
| Metric | RNAC | RXST |
|---|---|---|
| Revenue CAGR (5Y) | -50.01% | 48.85% |
| Total return CAGR (5Y) | -44.03% | -19.19% |
Frequently asked
- Which has grown faster, RNAC or RXST?
- Over the past five years, RXST grew revenue faster — RNAC at a -50.01% CAGR versus RXST at 48.85%.
- How have RNAC and RXST total returns compared?
- Over the past 5 years, RNAC delivered -44.03% and RXST delivered -19.19% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cartesian Therapeutics ROERxSight ROECartesian Therapeutics operating marginRxSight operating marginCartesian Therapeutics revenue growthRxSight revenue growthCartesian Therapeutics free cash flowRxSight free cash flow
Cartesian Therapeutics & RxSight appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.